Patients in the AKI cohort had a higher baseline CRP, with a median of 104.00nmol/L (IQR 51.00–196.00) compared to 59.00nmol/L (IQR 23.00–119.25), and was a significant risk factor for the development of AKI; OR 1.01, 95% CI 1.00–1.01, p<0.001. The gene discussed is CRP; the disease is acute kidney injury.